Monday 28 January 2013

EACPT Geneva 2013: Symposium on treating rare inborn errors of metabolism : from theory to practice


Abstract submission is now open for the next EACPT Congress, to be held in Geneva 28-31 August 2013. The congress includes symposia, keynote lectures and peer-reviewed oral and poster communications.
Symposium on treating rare inborn errors of metabolism : from theory to practice
Inborn errors of metabolism represent a relatively new and rapidly expanding class of genetic diseases. Signs and symptoms can affect all organs and may start at any age, from infancy to old age. Tremendous advances in laboratory techniques have led the way to the identification of hundreds of different diseases, requiring development of very diverse new therapeutic approaches, such as enzyme replacement or pharmacological chaperone therapies.
Inborn errors of metabolism offer not only new niches for orphan drug developers, but also models to get a better understanding of physiological pathways that play a role in many, more common diseases.
2013 EACPT Congress
Over 900 participants are expected to attend including health professionals, scientists, policy makers, biotechnology and pharmaceutical professionals, and others with an interest in basic and clinical pharmacology, pharmacotherapy, drug discovery and development, regulatory affairs and related areas.
EACPT Geneva 2013 Congress website  www.eacpt2013.org

No comments:

Post a Comment